Fujimi, Japan

Takeaki Hirano


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1977-1978

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Takeaki Hirano: Innovator in Pharmaceutical Composition

Introduction

Takeaki Hirano is a prominent inventor based in Fujimi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating various medical conditions. With a total of 3 patents to his name, Hirano's work has the potential to impact the health and well-being of many individuals.

Latest Patents

Hirano's latest patents include a pharmaceutical composition and method for the prevention and treatment of gastritis and peptic ulcers in mammals, including humans. This composition features a bis(benzamido)benzene derivative as the active ingredient. Additionally, he has developed bis(benzamido)-benzene derivatives that exhibit various pharmaceutical activities, such as preventing and treating peptic ulcers, peripheral vasodilating action, hypotensive activity, and analgesic activity.

Career Highlights

Hirano is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work at this organization has allowed him to focus on innovative solutions in the pharmaceutical sector. His dedication to research and development has led to advancements that could benefit countless patients.

Collaborations

Hirano collaborates with Sakae Takaku, a fellow innovator in the field. Their partnership has fostered a creative environment that encourages the exploration of new ideas and solutions in pharmaceuticals.

Conclusion

Takeaki Hirano's contributions to pharmaceutical innovation demonstrate his commitment to improving healthcare through scientific research. His patents reflect a deep understanding of medicinal chemistry and a desire to address pressing health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…